About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Studies for Inflammatory Bowel Disease

by Enozia Vakil on March 23, 2013 at 10:55 AM
Font : A-A+

 New Studies for Inflammatory Bowel Disease

The Chrohn's and Colitis Foundation of America arranges a meet of the top researchers in inflammatory bowel disease once in every five years, to set the research agenda for the next five years. The findings and recommendations of these expert workgroups are presented in a series of detailed "Challenges in IBD Research" reports, now available in Inflammatory Bowel Diseases, official journal of the CCFA.

Each workgroup is assigned to specific topic areas including genetics, epidemiology and environmental factors, the "microbiome" (intestinal bacteria), epithelial cell biology, innate and adaptive immunity, clinical classification and prognostic models, and optimizing medical therapy. A special "Challenges in IBD Research" progress report appears in the March issue of Inflammatory Bowel Diseases. The complete workgroup reports are available for direct download at http://links.lww.com/IBD/A77.

Advertisement

Experts Outline New Agenda for IBD Research Based on a thorough review in each area, the workgroups have defined key research priorities for the next few years, including:
  • Defining clinically relevant subgroups of IBD patients—using different types of information to predict aggressiveness of disease, complications, and response to treatment.
  • Understanding the environmental factors affecting the risk and course of IBD—including environmental "triggers" and a specific focus on the role of diet.
  • Clarifying the complex interrelationships among genes, bacteria, and epithelial and immune responses—focusing on cellular pathways and critical cell types that may lead to new "therapeutic targets."
  • Determining the optimal treatment approaches and strategies through comparative effectiveness studies.

The workgroup reports also identify the resources needed to carry out this ambitious research agenda, including a "centralized and distributable infrastructure" for integrated studies of IBD in humans and long-term follow-up studies of children and adults with IBD.
Advertisement

"Through development of the ambitious research goals outlined in this document, the Crohn's & Colitis Foundation of America has again led the effort to further the understanding of IBD," said Dr. Lee Denson of Cincinnati Children's Hospital Medical Center. "CCFA is keen to advance this research agenda in 2013 and beyond."

Building on Recent Scientific and Clinical Advances The CCFA research agenda builds on recent advances in scientific and clinical research. They include major strides in IBD genetics—more than 160 genes affecting susceptibility to Crohn's disease and ulcerative colitis have now been identified. Using sophisticated techniques, researchers have gained new insights into the complex interactions between intestinal bacteria and immune responses, including the role of specific types of immune cells.

Clinical studies have improved the ability to predict the response to IBD treatment in children and to track the short- and long-term adverse effects of IBD treatments. Progress has also been made in understanding the risks and benefits of medical and surgical treatments for key patient subgroups, including pregnant women and newborns. These studies point the way toward future efforts to optimize treatment for individual patients with IBD.



Source: Eurekalert
Advertisement
<< Ninjas Gather in Japan to Train Women in Self Defence
New Chemo Drug to Preserve Fertility and Expand Cancer Figh... >>

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Resource
Advertisement
News Category
What's New on Medindia
Western Diet may Augment the Risk of Autoimmune Diseases
Black Tea Protects against Blood Pressure and Heart Diseases
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Colo-rectal cancer - Management Crohns Disease Inflammatory Bowel Disease 

Recommended Reading
Study Says IBD Travelers are Not at Higher Risk of Contracting Intestinal Infections
A new study has found that inflammatory bowel disease (IBD) travelers have an increased risk of ......
Researchers Find 71 New Genetic Regions Linked With IBD
An additional 71 genetic regions have been identified by researchers to be linked with inflammatory ...
Clinical Trials Not Using Typical IBD Cases for Development of New Drugs
A new study reveals that the type of IBD cases being used to conduct major randomized controlled ......
Skin Cancer Risk Higher in IBD Patients
Patients with inflammatory bowel disease (IBD) face an increased risk of skin cancer, show studies....
Colo-rectal cancer - Management
Treatment for Colorectal Cancers may involve surgery,chemotherapy, radiation therapy or biological t...
Crohns Disease
Crohn’s disease or regional enteritis is an inflammatory bowel disease that involves the small intes...
Inflammatory Bowel Disease
Inflammatory bowel disease involves chronic inflammation of the colon and small intestine. Symptoms ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)